Cognizant Recognized in IDC MarketScape as a Leader in IT and BPO Services Across the Entire Life Sciences Value Chain: Research

  Cognizant Recognized in IDC MarketScape as a Leader in IT and BPO Services
    Across the Entire Life Sciences Value Chain: Research and Development,
           Manufacturing and Supply Chain, and Sales and Marketing

Cognizant Also Named a Leader in Strategic Consulting in Manufacturing and
Supply Chain, and Sales and Marketing

PR Newswire

TEANECK, N.J., Feb. 20, 2014

TEANECK, N.J., Feb. 20, 2014 /PRNewswire/ --Cognizant (NASDAQ: CTSH) today
announced that it has been positioned as a "Leader" in the IDC Health Insights
"IDC MarketScape" worldwide IT and BPO vendor assessments* across the entire
life sciences value chain: Research and Development, Manufacturing and Supply
Chain, and Sales and Marketing. Cognizant was also named a "Leader" in
Strategic Consulting across Manufacturing and Supply Chain, and Sales and
Marketing.

The evaluations were based on a comprehensive framework, and assessed service
providers across key characteristics, including functionality or offering road
map, delivery model, portfolio strategy, customer base, go-to-market
capabilities, customer references, pricing model, sales/distribution strategy,
marketing strategy, engagement capabilities, growth strategy, financial and
funding model, employee strategy, and innovation/R&D pace and productivity.

"Cognizant has extensive experience working with life sciences companies
across all three sections of the industry: pharmaceutical, biotech, and
medical devices," the reports noted. Based on feedback from multiple customer
references, Cognizant scored high marks for technical skills, project/account
management capabilities, understanding of clients' business needs, ability to
rapidly staff projects to minimize business disruption, and overall value
delivered to clients.

"Being the only company to be positioned as a Leader in eight of the nine
reports spanning the life sciences value chain validates our extensive
industry experience and integrated service capability to help life sciences
companies remain competitive for the future," said Shankar Narayanan, Vice
President of Cognizant's Life Sciences practice. "To maximize returns and
enhance agility, life sciences companies must optimize clinical systems and
pharmaceutical discovery, pre-clinical, and product development processes,
while building a stronger compliance foundation, streamlining the managed
markets lifecycle, and strengthening customer and stakeholder relationships.
Maintaining market leadership is no longer just about 'running better' by
enhancing clinical operations, drug safety, and sales effectiveness. It is
also about 'running different' by developing new strategies, skills, and
routes to market, adopting best-in-class industry practices, and leveraging
next-generation SMAC (social, mobile, analytics, and cloud) technologies to
improve health outcomes. In Cognizant, life sciences companies have a partner
who can help them balance between highly regulated and rapidly innovating
environments."

"Under increasing market and regulatory pressure, life sciences companies are
looking to improve enterprise agility, develop drugs faster, and eliminate
waste from all manufacturing and supply chain–related processes," said Eric
Newmark, Program Director of IDC Health Insights' Commercial Life Sciences
research. "Companies are also looking to automate and optimize reoccurring
sales activities, consolidate disparate information sources, optimize
multichannel sales and marketing operations, improve sales force effectiveness
and efficiency, and broaden their adoption and utilization of mobile
platforms. Many companies are expanding BPO into knowledge-based areas such as
analytics, business intelligence, and predictive modeling. There continues to
be strong demand for external partners that have strong life sciences–specific
industry expertise and can help life sciences companies design and optimize
enterprise technologies and go-to-market strategies, while improving
regulatory compliance capabilities."

"BPO in the life sciences industry is growing rapidly as companies have
determined that tasks like clinical data management and drug safety are
activities that can be competently outsourced to external service providers,
yielding both operational agility and direct cost savings," said Alan Louie,
Research Director of IDC Health Insights' clinical development, technology,
and strategy research. "Data- and information-centric activities will likely
remain under the domain of IT service providers, based on their superior
pricing capabilities and the ability to leverage their cross-industry IT
expertise with industry-specific knowledge. This bodes well for the life
sciences R&D BPO IT vendor ecosystem, which should continue to grow over the
foreseeable future."

*Cognizant was positioned as a "Leader" in the following reports:

1."IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain
    ITO 2013 Vendor Assessment" (document number #HI244265, dated November
    2013)
2."IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain
    Strategic Consulting 2013 Vendor Assessment" (document number #HI244494,
    dated November 2013)
3."IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain
    BPO 2013 Vendor Assessment" (document number #HI244446, dated November
    2013) 
4."IDC MarketScape: Worldwide Life Science Sales and Marketing ITO 2013
    Vendor Assessment" (document number #HI243591, dated October 2013)
5."IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic
    Consulting 2013 Vendor Assessment" (document number #HI244309, dated
    November 2013)
6."IDC MarketScape: Worldwide Life Science Sales and Marketing BPO 2013
    Vendor Assessment" (document number #HI243884, dated October 2013)
7."IDC MarketScape: Worldwide Life Science R&D ITO 2013 Vendor Assessment"
    (document number #HI245309, dated January 2014)
8."IDC MarketScape: Worldwide Life Science R&D BPO 2013 Vendor Assessment"
    (document number #244934, dated December 2013)

Cognizant was positioned as a "Major Player" in the following report:

  o"IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services
    2014 Vendor Assessment" (document number #HI246518, dated February 2014) 

About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of
the competitive fitness of ICT (information and communications technology)
suppliers in a given market. The research methodology utilizes a rigorous
scoring methodology based on both qualitative and quantitative criteria that
results in a single graphical illustration of each vendor's position within a
given market. IDC MarketScape provides a clear framework in which the product
and service offerings, capabilities and strategies, and current and future
market success factors of IT and telecommunications vendors can be
meaningfully compared. The framework also provides technology buyers with a
360-degree assessment of the strengths and weaknesses of current and
prospective vendors.

About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice is committed to helping
change millions of lives for the better by partnering with clients to build
solutions to healthcare challenges, continually improve the way they do
business, set the pace in clinical development, strengthen their regulatory
infrastructure, and increase competitiveness. Consistently ranked among the
top 10 on the Healthcare Informatics Top 100, Cognizant serves 27 of the top
30 global pharmaceutical companies, 15 of the top 20 health plans in the U.S.,
5 of the top 6 pharmacy benefit management companies in the U.S., 9 of the top
10 biotech companies, and 12 of the top 20 medical device companies. With a
large team of dedicated professionals including doctors, pharmacologists,
physicians, biomedical engineers, pharmacists, biostatisticians, medical
writers, and GxP consultants, the practice provides domain-aligned consulting,
IT, business process and analytics solutions globally.

About Cognizant
Cognizant (NASDAQ: CTSH) is a leading provider of information technology,
consulting, and business process outsourcing services, dedicated to helping
the world's leading companies build stronger businesses. Headquartered in
Teaneck, New Jersey (U.S.), Cognizant combines a passion for client
satisfaction, technology innovation, deep industry and business process
expertise, and a global, collaborative workforce that embodies the future of
work. With over 50 delivery centers worldwide and approximately 171,400
employees as of December 31, 2013, Cognizant is a member of the NASDAQ-100,
the S&P 500, the Forbes Global 2000, and the Fortune 500 and is ranked among
the top performing and fastest growing companies in the world. Visit us online
at www.cognizant.com or follow us on Twitter: Cognizant. 

Forward-Looking Statements
This press release includes statements which may constitute forward-looking
statements made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995, the accuracy of which are
necessarily subject to risks, uncertainties, and assumptions as to future
events that may not prove to be accurate. Factors that could cause actual
results to differ materially from those expressed or implied include general
economic conditions and the factors discussed in our most recent Form 10-K and
other filings with the Securities and Exchange Commission. Cognizant
undertakes no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or otherwise.

SOURCE Cognizant

Website: http://www.cognizant.com
Contact: U.S.: Marina Giovannelli, Text100, +1-786-266-3007,
marina.giovannelli@text100.com; Europe: Grazia Valentino-Boschi, + 33 (0)6 07
85 80 63, grazia.valentino-boschi@cognizant.com; Asia-Pac: Harsh Kabra,
+91-855-188-2111, harsh.kabra@cognizant.com
 
Press spacebar to pause and continue. Press esc to stop.